The Food and Drug Administration warned doctors on Thursday about reports of suicidal thinking in some children and adolescents who are taking Strattera, a drug used to treat attention deficit hyperactivity disorder (ADHD).

Manufacturer Eli Lilly & Co. announced that a black-box warning will be added to the drug's label in the United States.

Such a warning is the most serious that can be added to a medication's label. Similar warnings will be added to the drug's labels in other countries.
Full article (281 words) »